Ethic Inc. Catalent, Inc. Transaction History

Ethic Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $31,558 - $35,842	-714 Reduced 9.67%	6,673 $303,000
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $81,083 - $171,176	-2,545 Reduced 25.62%	7,387 $320,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $167,855 - $274,316	3,694 Added 59.22%	9,932 $652,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $87,788 - $171,801	2,121 Added 51.52%	6,238 $280,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $31,621 - $49,424	-437 Reduced 9.6%	4,117 $298,000
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $374,698 - $490,072	-4,297 Reduced 48.55%	4,554 $489,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $431,578 - $570,413	4,582 Added 107.33%	8,851 $982,000
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $71,144 - $82,746	-595 Reduced 12.23%	4,269 $547,000
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $520,195 - $678,297	-4,765 Reduced 49.49%	4,864 $647,000
Q2 2021 Aug 10, 2021	BUY	$100.34 - $115.69 $322,191 - $371,480	3,211 Added 50.03%	9,629 $1.04 Million
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $365,943 - $451,598	3,605 Added 128.15%	6,418 $676,000
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $241,580 - $296,377	2,813 New	2,813 $293,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

Stay updated on Ethic Inc. with notifications on news.